Blair William & CO Nevro Corp Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Nevro Corp stock. As of the latest transaction made, Blair William & CO holds 47,504 shares of NVRO stock, worth $214,718. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,504

Previous 59,404 20.03%

Holding current value

$214,718

Previous $500,000 47.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$4.71 - $10.1 $56,049 - $120,190	-11,900 Reduced 20.03%	47,504 $265,000
Q2 2024 Aug 12, 2024	BUY	$7.96 - $13.59 $57,710 - $98,527	7,250 Added 13.9%	59,404 $500,000
Q1 2024 May 09, 2024	BUY	$13.56 - $20.78 $186,450 - $285,725	13,750 Added 35.8%	52,154 $753,000
Q4 2023 Feb 12, 2024	SELL	$14.18 - $22.31 $219,166 - $344,823	-15,456 Reduced 28.7%	38,404 $826,000
Q3 2023 Nov 09, 2023	BUY	$18.22 - $25.85 $300,903 - $426,912	16,515 Added 44.22%	53,860 $1.04 Million
Q2 2023 Aug 11, 2023	BUY	$22.62 - $39.32 $661,996 - $1.15 Million	29,266 Added 362.25%	37,345 $949,000
Q1 2023 May 12, 2023	BUY	$30.17 - $41.11 $31,195 - $42,507	1,034 Added 14.68%	8,079 $292,000
Q4 2022 Feb 10, 2023	SELL	$36.43 - $49.4 $870,786 - $1.18 Million	-23,903 Reduced 77.24%	7,045 $278,000
Q3 2022 Nov 09, 2022	SELL	$40.66 - $53.03 $379,967 - $495,565	-9,345 Reduced 23.19%	30,948 $1.44 Million
Q2 2022 Aug 10, 2022	SELL	$40.85 - $77.67 $437,176 - $831,224	-10,702 Reduced 20.99%	40,293 $1.77 Million
Q1 2022 May 13, 2022	BUY	$59.95 - $92.06 $121,099 - $185,961	2,020 Added 4.12%	50,995 $3.69 Million
Q4 2021 Feb 14, 2022	BUY	$81.07 - $121.29 $189,136 - $282,969	2,333 Added 5.0%	48,975 $3.97 Million
Q3 2021 Nov 12, 2021	SELL	$101.99 - $166.36 $82,203 - $134,086	-806 Reduced 1.7%	46,642 $5.43 Million
Q2 2021 Aug 12, 2021	BUY	$141.6 - $179.06 $194,558 - $246,028	1,374 Added 2.98%	47,448 $7.87 Million
Q1 2021 May 13, 2021	BUY	$132.81 - $182.18 $227,901 - $312,620	1,716 Added 3.87%	46,074 $6.43 Million
Q4 2020 Feb 09, 2021	BUY	$138.17 - $184.34 $114,266 - $152,449	827 Added 1.9%	44,358 $7.68 Million
Q3 2020 Nov 06, 2020	BUY	$114.09 - $145.51 $185,852 - $237,035	1,629 Added 3.89%	43,531 $6.06 Million
Q2 2020 Aug 12, 2020	BUY	$89.45 - $129.85 $139,720 - $202,825	1,562 Added 3.87%	41,902 $5.01 Million
Q1 2020 May 11, 2020	BUY	$70.23 - $144.31 $9,691 - $19,914	138 Added 0.34%	40,340 $4.03 Million
Q4 2019 Feb 13, 2020	SELL	$76.41 - $117.54 $395,116 - $607,799	-5,171 Reduced 11.4%	40,202 $4.73 Million
Q3 2019 Nov 12, 2019	SELL	$61.52 - $91.1 $1.84 Million - $2.73 Million	-29,972 Reduced 39.78%	45,373 $3.9 Million
Q2 2019 Aug 13, 2019	BUY	$58.04 - $66.99 $94,373 - $108,925	1,626 Added 2.21%	75,345 $4.89 Million
Q1 2019 May 14, 2019	SELL	$35.52 - $62.62 $566,792 - $999,227	-15,957 Reduced 17.79%	73,719 $4.61 Million
Q4 2018 Feb 14, 2019	SELL	$35.43 - $56.29 $2.21 Million - $3.51 Million	-62,318 Reduced 41.0%	89,676 $3.49 Million
Q3 2018 Nov 13, 2018	SELL	$44.22 - $75.47 $767,880 - $1.31 Million	-17,365 Reduced 10.25%	151,994 $8.66 Million
Q2 2018 Aug 13, 2018	SELL	$72.38 - $92.5 $4.26 Million - $5.44 Million	-58,793 Reduced 25.77%	169,359 $13.5 Million
Q1 2018 May 15, 2018	SELL	$69.46 - $88.57 $4.71 Million - $6.01 Million	-67,875 Reduced 22.93%	228,152 $19.8 Million
Q4 2017 Feb 14, 2018	BUY	$65.94 - $93.31 $644,101 - $911,452	9,768 Added 3.41%	296,027 $20.4 Million
Q3 2017 Nov 13, 2017	BUY	$80.87 - $91.08 $23.1 Million - $26.1 Million	286,259	286,259 $26 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $160M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account